Consultation on potential Ebola therapies and vaccines
Place: Geneva, Swizerland
Date: 4-5 September 2014
The current west African Ebola outbreak is unprecedented in size, complexity and the strain it has imposed on health systems. There is intense public interest in, and demand for, anything that offers hope of definitive treatment. A range of unproven interventions-blood products, immune therapies, drugs and vaccines are under different stages of development but none have yet been licensed for standard use.
In early August, an expert panel convened by WHO concluded that, in the particular circumstances of this outbreak, and provided certain conditions are met, it is ethical to offer such unproven interventions as potential treatments or for prevention of infection.
This week, on September 4-5, WHO is bringing together technical experts from the groups developing Ebola interventions along with people working to overcome Ebola virus disease including policy-makers from Ebola affected countries, ethicists, clinicians, researchers, regulators and patient representatives.
The purpose of this meeting
- Review and evaluate the current state of development of interventions for Ebola virus disease (therapies and vaccines).
- Agree the overall objectives for a plan for evaluation and use of potential interventions.
- Identify the most important actions that need to be taken.
- Establish what support is required.
Agenda of the Consultation on potential Ebola therapies and vaccines
List of participants